₹48.99
▼ -0.32 -0.65%
As of 30 Jul 2026 · delayed
BSE Listed
EIKO Lifesciences Limited (540204)
Volume: 966Avg Vol 1W: 2,315Avg Vol 1M: 7,80352W Range:₹45.9₹64.44
Key Ratios
Checked 11h agoMarket Cap₹71 Cr
Current Price₹48.99
Previous Close₹49.31
High / Low (52w)₹64.44 / ₹45.9
Volume966
Avg Vol (1W)2,315
Avg Vol (1M)7,803
Stock P/E15.73
Book Value₹47.94
Dividend Yield0%
ROE6.54%
ROA5.95%
Revenue (TTM)—
Revenue Growth—
Profit Margin8.54%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹3.13
P/B1.03
Debt / Equity0.05
50 DMA₹50.45
200 DMA₹51.67
Day change-0.65%
Price Chart
₹48.99▼ 12.39% · 1Y
2025-07-302026-07-30
20-day avg volume: 8K shares
Pros
- Company is almost debt-free.
- Revenue grew 66% YoY.
- Net profit is growing year over year.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹11 Cr | ₹8 Cr | ₹7 Cr | ₹11 Cr | ₹11 Cr | ₹12 Cr | ₹12 Cr | ₹18 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹38 Cr | ₹7 Cr | ₹9 Cr | ₹10 Cr | ₹16 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| EPS | — | — | — | 1.62 | — | — | — | — |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | ₹11 Cr | ₹9 Cr | ₹12 Cr | ₹66 Cr |
| Total Liabilities | ₹5 Cr | ₹5 Cr | ₹11 Cr | ₹9 Cr |
| Equity | ₹6 Cr | ₹5 Cr | ₹1 Cr | ₹57 Cr |
| Total Debt | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2025 |
|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹3 Cr |
| Investing | ₹0 Cr | ₹-1 Cr | ₹-11 Cr |
| Financing | ₹-1 Cr | ₹1 Cr | ₹7 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹3 Cr |
Shareholding
Promoter 39.91% Institutions 0% Public 60.09%
Efficiency & Working Capital
ROCE10.1%
Interest Coverage17
Dividend Payout—
Debtor Days105 d
Inventory Days56 d
Payable Days32 d
Cash Conversion Cycle128 d
Working Capital Days160 d
Shareholding Details
As of 2026-06-30
Promoter39.9%
FII0%
DII0%
Institutions0%
Public60.1%
Promoter Pledge0%
No. of Shareholders3,019
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Mar 2025 | Jun 2025 | Aug 2025 | Sept 2025 | Dec 2025 | Feb 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 24.4% | 31.3% | 31.3% | 31.3% | 36.2% | 36.7% | 37.1% | 37.2% | 37.2% | 39.9% | 39.9% | 39.9% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 75.6% | 68.7% | 68.7% | 68.7% | 63.8% | 63.3% | 62.9% | 62.8% | 62.8% | 60.1% | 60.1% | 60.1% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 3,140 | 3,199 | 3,456 | 3,565 | 3,336 | 3,322 | 3,203 | 3,150 | 3,092 | 3,028 | 2,969 | 3,019 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Lenus Finvest Private Limited | Shareholding of Promoter and Promoter Group | 17.7% | 25,40,472 |
| Laxmikant Kabra (huf) | Shareholding of Promoter and Promoter Group | 9.9% | 14,20,000 |
| 2b Black Bio Llp | Public Shareholding | 9.7% | 13,85,672 |
| Bhavesh Dhirajlal Tanna | Shareholding of Promoter and Promoter Group | 5.9% | 8,40,000 |
| Siddhant Laxmikant Kabra | Shareholding of Promoter and Promoter Group | 5.6% | 8,07,650 |
| Ashika Global Finance Private Limited | Public Shareholding | 4.2% | 6,00,864 |
| Ashok Vishwanath Hiremath | Public Shareholding | 3.7% | 5,33,333 |
| Sushila Paraskumar Daga | Public Shareholding | 2.8% | 3,98,881 |
| Sivanesan Sellappan | Public Shareholding | 2% | 2,90,029 |
| Joyanta Kumar Jana | Public Shareholding | 2% | 2,85,135 |
| Parshva Kumar Daga | Public Shareholding | 1.7% | 2,40,630 |
| Bhavinkumar Vinaychand Shah | Public Shareholding | 1.4% | 1,94,109 |
| Kaushik Daga | Public Shareholding | 1.1% | 1,58,926 |
| Laxmikant Ramprasad Kabra | Shareholding of Promoter and Promoter Group | 0.8% | 1,16,666 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Laxmikant Kabra | Chairman & Non Executive Dir. | 2025 |
| Bhavesh Dhirajlal Tanna | Non-Exec & Non-Independent Dir | 2025 |
| Rajkumar K Baheti | Independent Non Exe. Director | 2025 |
| Kajal Dhanpatraj Kothari | Independent Non Exe. Director | 2025 |
| Hasti Doshi | Independent Non Exe. Director | 2025 |
| Sumukh Prabhakar Vartak | Whole-time Director | 2025 |
| CHINTAN BHARATBHAI DOSHI | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 14 | 14 | 14 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 8 | 6 | 1 | 0 | 0 | 16 |
| 2025 | 8 | 0 | 1 | 0 | 0 | 9 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Substantial Acquisitions (SAST)
2 disclosure(s)
Pref. Allotment24/02/2026 · 1,75,000
Pref. Allotment24/02/2026 · 4,50,000
Company Information
🌐 www.eikolifesciences.com ↗
📍 1st Matru Chhaya Ground Floor, M Karve Road Naupada, Thane, Maharashtra, 400602
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Salem Erode Investments LimitedUnipro Technologies LimitedFranklin Industries LimitedLKP Securities LimitedOsiajee Texfab LimitedCorporate Merchant Bankers Ltd.Shashank Traders LimitedNew Light Industries LimitedViram Suvarn LimitedMarg Techno Projects LimitedShangar Decor LimitedGlobe Commercials LimitedAll “54” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search